NYC-WTC_000195164

NYC 9/11 Public Portal Document

.. , ASBESTOS REPROTEXT ® System Page 26 of 27

sputum. Eur Resp J 1996; 9:680-686. 339. Timblin CR, Janssen YWM & Mossman BT: Transcriptional activation of the proto­ oncogene c-jun by asbestos and H2O2 is directly related to increased proliferation and transformation of tracheal epithelial cells. Cancer Res 1995; 55:2723-2726. 340. Tokiwa T et al: Igaku No Ayumi 1983; 127:807-808. 341. Truhaut R & Chouroulinkov I: Effect of long-term ingestion of asbestos fibres in rats. lARC Sci Publ 1989; 90:127-133. 342. Tuomi T, Huuskonen MS, Virtamo M et al: Relative risk of mesothelioma associated with different levels of exposure to asbestos. Scand J Work Environ Health 1991; 17:404-408. 343. Vainio H, Husgafvelpursiainen K, Anttila S et al: Interaction between smoking and asbestos in human lung adenocarcinoma — role of k-ras mutations. Environ Health Perspect 1993; 101(Suppl 3):189-192 344. Valerio F et al: lARC Sci Pub 30: Iss Biol Eff Miner Fibres VI: 485-489, 1980; 38:470- 474. 345. Valerio F et al: Mutat Res 1983; 122:397-402. 346. Vasama-Neuvonen K, Pukkala E & Paakkalainen H: Ovarian cancer and occupational exposures in Finland. Am J Ind Med 1999; 36:83-89. 347. Wagner GR: Asbestosis and silicosis. Lancet 1997; 349:1311-1315. 348. Warnock ML & Churg AM: Association of asbestos and bronchogenic carcinoma in a population with low asbestos exposure. Cancer 1975; 35:1236-1242. 349. Warnock ML: Lung asbestos burden in shipyard and construction workers with mesothelioma: comparison with burdens in subjects with asbestosis or lung cancer. Environ Res 1989; 50:68-85. 350. Watanabe M, Kimura N, Kato M et al: An autopsy case of malignant mesothelioma associated with asbestosis. Pathol International 1994:44:785-792. 351. Weil H, Hughes J & Waggenspack C: Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis 1979; 120:345- 354. 352. Weill H & Hughes JM: Asbestos health effects: resolving the scientific uncertainties. Postgrad Med J 1988; 64(Suppl 4):48-55. 353. Weiss W: Asbestos and colorectal cancer. Gastroenterology 1990; 99:876-884. 354. Weiss W: The attribution of lung cancer to asbestos (Letter). Chest 1993; 2:654-655. 355. Weiss W: The lack of causality between asbestos and colorectal cancer. J Occup Environ Med 1995; 37:1364-1373. 356. Wilkinson P, Hansell DM, Janssens J et al: Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph. Lancet 1995; 345:1074-1078. 357. Wylie AG & Bailey KF: The mineralogy and size of airborne chrysotile and rock fragments - ramifications of using the NIOSH 7400 Method. Am Ind Hyg Assoc J 1992; 53:442-447. 358. Xu A, Wu LJ, Santella RM et al: Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. Cancer Res 1999; 59:5922-5926. 359. Yegles M, Saint-Etienne L, Renier A et al: Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1993; 9:186-191. 360. Zejda JE: Occupational exposure to dusts containing asbestos and chronic airways disease. Internal J Occup Med Environ Health 1996; 9:117-125. 361. Zenz C: Occupational Medicine, 3rd ed. Mosby - Year Book, Inc, St Louis, MO, 1994, pp 179-182.

http://www.tomescps.eom/D AT A/RE/RE356.HTM?Top=Yes 1/4/2002

CITY_21MC100_011105169

NYC-WTC_000195189